Monopar Therapeutics Inc. financial statements
Monopar Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | 10-K |
| Net income | −USD 13.72M | 10-K |
| Cash and equivalents | USD 61.83M | 10-Q |
| Total debt | USD 154.92K | EODHD |
Monopar Therapeutics Inc. financials on 6ix · Monopar Therapeutics Inc. on 6ix